NCT05689671 2026-03-10ANTELOPECharite University, Berlin, GermanyPhase 4 Active not recruiting136 enrolled
NCT06106802 2026-02-23Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib TreatmentSamsung Medical CenterPhase 2 Recruiting47 enrolled